Description:Ingavirin, with the CAS number 219694-63-0, is an antiviral medication primarily used in the treatment of influenza and other viral infections. It is characterized by its mechanism of action, which involves the modulation of the immune response and inhibition of viral replication. Ingavirin is known for its ability to enhance the production of interferons, which are proteins that play a crucial role in the body's defense against viral infections. The substance is typically administered orally and is recognized for its relatively low toxicity profile. Ingavirin is often noted for its rapid onset of action and is usually prescribed for use in the early stages of viral infections. Its chemical structure includes a core imidazole ring, contributing to its biological activity. While it is effective against various strains of influenza, its use should be guided by medical advice, considering potential contraindications and interactions with other medications. Overall, Ingavirin represents a significant option in antiviral therapy, particularly in regions where influenza is prevalent.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.